2,662 reports of this reaction
3.1% of all FULVESTRANT reports
#4 most reported adverse reaction
DEATH is the #4 most commonly reported adverse reaction for FULVESTRANT, manufactured by AstraZeneca Pharmaceuticals LP. There are 2,662 FDA adverse event reports linking FULVESTRANT to DEATH. This represents approximately 3.1% of all 86,552 adverse event reports for this drug.
Patients taking FULVESTRANT who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among FULVESTRANT users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for FULVESTRANT:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 2,662 FDA reports for FULVESTRANT. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 3.1% of all adverse event reports for FULVESTRANT, making it a notable side effect.
If you experience death while taking FULVESTRANT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.